Jiangsu Yangdian Science & Technology Co. Ltd.

SZSE:301012.SZ

21.14 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 324.92232.988269.42164.03162.54378.06494.96121.7226.519191.728147.272130.075147.36286.932121.105116.97144.16655.87119.7214.6164.616-3.21-3.215.9855.985
Cost of Revenue 269.271203.341241.279143.03752.30367.94382.76895.741174.172149.71116.985111.873111.21767.85295.993-150.507109.52640.98103.5333.5331.7841.7844.9384.938
Gross Profit 55.6529.64728.14120.99510.23910.1212.19225.95852.34742.01830.28718.20236.14519.0825.112267.47734.6414.889119.7211.0831.083-4.994-4.9941.0481.048
Gross Profit Ratio 0.1710.1270.1040.1280.1640.130.1280.2130.2310.2190.2060.140.2450.2190.2072.2870.240.26710.2350.2351.5561.5560.1750.175
Reseach & Development Expenses 4.6947.299.7233.8672.9083.1055.1465.558.9617.1585.3164.0794.1872.9885.3823.7213.8922.8860000000
General & Administrative Expenses -0.3925.457-6.11110.456-0.0413.588-6.71710.5740.222.847-3.0687.085-0.2051.9962.213.66-4.1971.31600.3940.3941.0981.0980.4170.417
Selling & Marketing Expenses 5.6944.0065.7822.7571.611.3183.7014.8554.3013.4472.836-1.1724.4253.4524.5473.9324.1423.10900.0620.0620.0470.0470.0370.037
SG&A 21.9589.56116.16213.2131.5694.906-3.01615.4294.5216.293-0.2325.9134.225.4485.6339.389-0.0554.42500.4560.4561.1451.1450.4540.454
Other Expenses 0.270.089-2.373-0.05-0.107-0.3080.176-3.501-0.353-0.084-0.429-0.29-0.028-0.189-106.164-255.77100-109.133000000
Operating Expenses 26.38216.76228.25911.85510.0038.4386.25716.76315.67213.7789.7422.15112.0058.747-106.164-255.77111.5916.659-109.1331.0291.0290.7270.7270.0290.029
Operating Income 29.26712.885-0.1186.086-4.230.962.18712.83133.58527.38616.91412.33620.6019.79314.94111.70623.2185.71810.5880.6090.609-2.597-2.5970.5690.569
Operating Income Ratio 0.090.055-00.037-0.0680.0120.0230.1050.1480.1430.1150.0950.140.1130.1230.10.1610.1020.0880.1320.1320.8090.8090.0950.095
Total Other Income Expenses Net 4.4461.0753.537-0.05-0.107-0.3080.176-3.501-0.353-0.084-0.429-0.29-0.028-0.189-0.0220.0410.126-1.82601.0721.0722.0712.0710.0250.025
Income Before Tax 33.71413.963.426.037-4.3360.6522.3629.3333.23227.30216.48612.04620.5739.60414.91911.74723.3445.71810.5881.6811.681-0.527-0.5270.5940.594
Income Before Tax Ratio 0.1040.060.0130.037-0.0690.0080.0250.0770.1470.1420.1120.0930.140.110.1230.10.1620.1020.0880.3640.3640.1640.1640.0990.099
Income Tax Expense 6.0861.241-0.456-0.328-0.2550.157-2.0940.9324.263.1921.9531.4712.5961.1351.861.6913.2770.4431.6530.2520.2520.0890.0890.0890.089
Net Income 27.66812.6693.9876.365-4.0810.4954.4568.39828.97224.1114.53310.57517.9778.46913.05910.05620.0685.8898.9351.4281.428-0.438-0.4380.5050.505
Net Income Ratio 0.0850.0540.0150.039-0.0650.0060.0470.0690.1280.1260.0990.0810.1220.0970.1080.0860.1390.1050.0750.3090.3090.1360.1360.0840.084
EPS 0.20.0890.0280.053-0.0350.0040.0380.0710.250.210.120.090.150.0930.150.110.230.06400.0080.0080000
EPS Diluted 0.20.0890.0280.05-0.0350.0040.0380.0710.250.20.120.090.150.0930.150.110.230.06400.0080.0080000
EBITDA 34.78813.0394.91510.918-0.1591.2786.2815.77737.59326.94114.78621.84623.88210.122-251.501280.51628.1838.283-300.4331.9331.933-1.273-1.3811.7851.785
EBITDA Ratio 0.1070.0560.0180.067-0.0030.0160.0660.0470.1660.1410.10.1680.1620.116-2.0772.3980.1950.148-2.5090.4190.4190.3970.430.2980.298